TENT5C and plasma cell myeloma: Through this mechanism, FAM46C is proposed to raise the ER secretory capacity to abnormally high levels, leading to reactive oxygen species (ROS) production, adenosine triphosphate (ATP) shortage, and ultimately cell death of multiple myeloma (15).